SC
CYTK icon

SouthState Corp’s Cytokinetics CYTK Stock Holding History

SouthState Corp’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28K Hold
15
– – ﹤0.01% 1051
2026
Q1 		$989 Hold
15
– – ﹤0.01% 1049
2025
Q4 		$954 Hold
15
– – ﹤0.01% 1125
2025
Q3 		$825 Hold
15
– – ﹤0.01% 1114
2025
Q2 		$496 Buy
15
+5
+50% +$174 ﹤0.01% 1442
2025
Q1 		$402 Buy
+10
New +$460 ﹤0.01% 1573

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SouthState Corp's CYTK Position: Q2 2026 in Review

SouthState Corp held its Cytokinetics (CYTK) position steady in Q2 2026 at 15 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

SouthState Corp first reported a position in CYTK in Q1 2025 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • SouthState Corp held 15 shares of Cytokinetics worth $1.28K as of Q2 2026.
  • SouthState Corp left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1051 holding.
  • SouthState Corp first reported a position in Cytokinetics in Q1 2025 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.